Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Minarik

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|July 24, 2009
Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomibJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Blood Reviews|April 22, 2019
Extramedullary disease in multiple myeloma - controversies and future directionsSabina Sevcikova, Jiri Minarik, Martin Stork, et al.
Leukemia & Lymphoma|October 29, 2009
Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myelomaJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Haematologica|December 7, 2005
The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myelomaVlastimil Scudla, Marta Ordeltova, Jaroslav Bacovsky, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 15, 2015
Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myelomaVlastimil Scudla, Pavel Lochman, Tomas Pika, et al.
Thescientificworldjournal|May 26, 2012
Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significanceJiri Minarik, Tomas Pika, Jaroslav Bacovsky, et al.
European Journal of Haematology|March 20, 2022
Bone metabolism parameters and their relation to cytogenetics in multiple myelomaPetra Krhovska, Tomas Pika, Jitka Proskova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 15, 2012
Comparison of imaging methods in POEMS syndromeJiri Minarik, Vlastimil Scudla, Jaroslav Bacovsky, et al.
Anticancer Research|September 4, 2020
<i>CDKN1A</i> Gene Expression in Two Multiple Myeloma Cell Lines With Different P53 FunctionalityDenisa Hrckova Drozdkova, Jan Gursky, Jiri Minarik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 8, 2016
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathiesJiri Minarik, Petra Krhovska, Jan Hrbek, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|July 24, 2009
Prognostic significance of apoptotic index in multiple myeloma patients treated by conventional therapy and novel agents, thalidomide and bortezomibJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Blood Reviews|April 22, 2019
Extramedullary disease in multiple myeloma - controversies and future directionsSabina Sevcikova, Jiri Minarik, Martin Stork, et al.
Leukemia & Lymphoma|October 29, 2009
Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple myelomaJiri Minarik, Vlastimil Scudla, Marta Ordeltova, et al.
Haematologica|December 7, 2005
The relationship between proliferation and apoptosis in patients with monoclonal gammopathy of undetermined significance or multiple myelomaVlastimil Scudla, Marta Ordeltova, Jaroslav Bacovsky, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|September 15, 2015
Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myelomaVlastimil Scudla, Pavel Lochman, Tomas Pika, et al.
Thescientificworldjournal|May 26, 2012
Prognostic value of hepatocyte growth factor, syndecan-1, and osteopontin in multiple myeloma and monoclonal gammopathy of undetermined significanceJiri Minarik, Tomas Pika, Jaroslav Bacovsky, et al.
European Journal of Haematology|March 20, 2022
Bone metabolism parameters and their relation to cytogenetics in multiple myelomaPetra Krhovska, Tomas Pika, Jitka Proskova, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|May 15, 2012
Comparison of imaging methods in POEMS syndromeJiri Minarik, Vlastimil Scudla, Jaroslav Bacovsky, et al.
Anticancer Research|September 4, 2020
<i>CDKN1A</i> Gene Expression in Two Multiple Myeloma Cell Lines With Different P53 FunctionalityDenisa Hrckova Drozdkova, Jan Gursky, Jiri Minarik, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|January 8, 2016
Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathiesJiri Minarik, Petra Krhovska, Jan Hrbek, et al.
Pageof 6